All News

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

When it comes to diabetes, that lack of a shared language can be a tremendous barrier to care.

Study examining the metabolic pathway points to existing therapies that may slow the growth of small cell lung cancer.

The opioid reversal agent Narcan (naloxone) was reportedly used to save singer Demi Lovato’s life after an apparent drug overdose, and pharmacists may get more questions this week about what this medication is used for and how to use it. A video below contains advice on how to answer those questions.

Dextromethorphan’s accessibility is one reason why teenagers tend to abuse it.

Officials with the FDA have approved elagolix (Orilissa, AbbVie), a product specifically developed for women with moderate to severe endometriosis pain.

Stay tuned all week to watch our Editor in Chief's RAGBRAI ride with the Iowa Pharmacy Association.

Stay tuned all week to watch our Editor in Chief's RAGBRAI ride with the Iowa Pharmacy Association.

The FDA has approved AbbVie's elagolix (Orilissa) product, a drug specifically developed for women with moderate to severe endometriosis pain.

Adding acetazolamide to chemotherapy temozolomide for glioblastoma increased sensitivity to treatment and improved survival in animal models.

The FDA has approved, under Priority Review, GlaxoSmithKline (GSK)’s tafenoquine (Krintafel), which is the first single-dose medicine for the prevention of Plasmodium vivax (P vivax) malaria relapse in patients over the age of 16 years who are receiving antimalarial therapy.

Study establishes increased risk of all-site cancer for both men and women with diabetes, but the excess risk of cancer is greater for women.

A recent systematic review and meta-analysis found that men with advanced cancers respond better than women to treatment with anti-PD-1 or anti-CTLA-4 immune checkpoint inhibitors.

Taking advantage of cost-effective generic medications can improve access to hepatitis B treatment, especially in countries with a high disease burden.

Many clinicians have been preparing for USP for a long time and are well on their way to compliance.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

Growing evidence suggests that integrating clinical pharmacy specialists into medical care teams that focus on diabetes improves glycemic control, and leads to better clinical outcomes in primary care settings.

A new research study, published in JAMA Cardiology, aimed to further confirm a previous correlation between asthma and atrial fibrillation (AF) and to determine if the degree of asthma control affected the risk of developing AF.

The FDA on Friday approved Pfizer's filgrastim-aafi, a filgrastim biosimilar to Amgen's Neupogen.

Data collected from a number of patient safety reporting programs indicate that between 2% and 35% of prescription errors are linked to look alike, sound alike drug name similarities.

There is a concern that mergers and acquisitions in the pharmacy space will lead to decreased competition and loose agreements between companies that will not drive significant outcomes.

Study suggests benzalkonium chloride, a preservative that has been used in ophthalmology since the 1940s, may be toxic to ocular structures.

Stay tuned all week to watch our Editor in Chief's RAGBRAI ride with the Iowa Pharmacy Association.

Top news of the day from across the health care landscape.

Top news of the day from across the health care landscape.

The HIV pandemic will likely continue to be a global challenge for the foreseeable future.

Mapping iron concentration in certain regions of the brain may help predict multiple sclerosis progression risk.

Approval for tafenoquine was granted based on the efficacy and safety data gleaned from a comprehensive global clinical development program for P vivax prevention of relapse,